Список литературы

Поставить закладку

Dehner L.P. Gonadal and extragonadal germ cell neoplasia of childhood // Hum. Pathol. 1983. Vol. 14, № 6. P. 493–511.
Göbel U. et al. Germ-cell tumors in childhood and adolescence. GPOH MAKEI and the MAHO study groups // Ann. Oncol. Off. J. Eur. Soc. Med. Oncol. 2000. Vol. 11, № 3. P. 263–271.
Детская онкология. Национальное руководство под редакцией М.Д. Алиева, В.Г. Полякова, Г.Л. Менткевича, С.А. Маяковой - сборник | ИСТИНА – Интеллектуальная Система Тематического Исследования НАукометрических данных [Electronic resource]. URL: https://istina.msu.ru/collections/441588665/ (accessed: 31.05.2024).
Calaminus G. et al. Age-Dependent Presentation and Clinical Course of 1465 Patients Aged 0 to Less than 18 Years with Ovarian or Testicular Germ Cell Tumors; Data of the MAKEI 96 Protocol Revisited in the Light of Prenatal Germ Cell Biology // Cancers. 2020. Vol. 12, № 3. P. 611.
Cecchetto G. Gonadal germ cell tumors in children and adolescents // J. Indian Assoc. Pediatr. Surg. 2014. Vol. 19, № 4. P. 189–194.
Hussain H.K. et al. Imaging-guided core biopsy for the diagnosis of malignant tumors in pediatric patients // AJR Am. J. Roentgenol. 2001. Vol. 176, № 1. P. 43–47.
Garbay D. et al. Bone marrow metastases in a patient with primary mediastinal non-seminomatous germ cell tumor - an unusual pattern of relapse // Onkologie. 2012. Vol. 35, № 1–2. P. 40–42.
Piazza M.J., Urbanetz A.A. Germ Cell Tumors in Dysgenetic Gonads // Clinics. 2019. Vol. 74. P. e408.
Lu L., Luo F., Wang X. Gonadal tumor risk in pediatric and adolescent phenotypic females with disorders of sex development and Y chromosomal constitution with different genetic etiologies // Front. Pediatr. 2022. Vol. 10. P. 856128.
Rich B.S. et al. Current surgical approach: Extracranial malignant germ cell tumors // Pediatr. Blood Cancer. 2024. P. e31217.
Marina N. et al. Treatment of childhood germ cell tumors. Review of the St. Jude experience from 1979 to 1988 // Cancer. 1992. Vol. 70, № 10. P. 2568–2575.
Marina N.M. et al. Complete surgical excision is effective treatment for children with immature teratomas with or without malignant elements: A Pediatric Oncology Group/Children’s Cancer Group Intergroup Study // J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 1999. Vol. 17, № 7. P. 2137–2143.
MAKEI 05 protocol (versie 1). – URL: https://prinsesmaxima.iprova.nl/Portal/#/QC/22-67-GH (дата обращения: 15.11.2024). – Текст : электронный.
Ongoing Clinical Trials in Testicular Cancer: The TIGER Trial | Oncology Research and Treatment | Karger Publishers. – URL: https://karger.com/ort/article/39/9/553/263230/Ongoing-Clinical-Trials-in-Testicular-Cancer-The (дата обращения: 15.11.2024). – Текст : электронный.
Einhorn L.H. et al. Phase II study of paclitaxel plus gemcitabine salvage chemotherapy for germ cell tumors after progression following high-dose chemotherapy with tandem transplant // J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 2007. Vol. 25, № 5. P. 513–516.
Bokemeyer C. et al. Combination chemotherapy with gemcitabine, oxaliplatin, and paclitaxel in patients with cisplatin-refractory or multiply relapsed germ-cell tumors: a study of the German Testicular Cancer Study Group // Ann. Oncol. Off. J. Eur. Soc. Med. Oncol. 2008. Vol. 19, № 3. P. 448–453.
Al F. et al. Comparison of carboplatin versus cisplatin in the treatment of paediatric extracranial malignant germ cell tumours: A report of the Malignant Germ Cell International Consortium // Eur. J. Cancer Oxf. Engl. 1990. Eur J Cancer, 2018. Vol. 98.
Patel P. et al. Interventions for the prevention of acute phase chemotherapy-induced nausea and vomiting in adult and pediatric patients: a systematic review and meta-analysis // Support. Care Cancer Off. J. Multinatl. Assoc. Support. Care Cancer. 2022. Vol. 30, № 11. P. 8855–8869.
Трахтман П.Е., Старостин Н.Н., Новичкова Г.А., Ворожцов И.Н. Трансфузионная терапия в клинической практике: учеб. пособие / Национальный медицинский исследовательский центр детской гематологии, онкологии и иммунологии им. Д. Рогачева. Москва, 2021. 76 с.
Румянцев А. Г. Федеральные клинические рекомендации по организации оптимально венозного доступа у детей с гематологическими, онкологическими и иммунологическими заболеваниями. / А. Г. Румянцев, А. А. Масчан, Д. Ш. Биккулова. – 2015.; Венозный катетер. Использование, уход, контроль, осложнения: учебное пособие / Сацук А.В., Солопова Г.Г., Щукин В.В., Литвинов Д.В., Пименова О.В. Климова Н.А., Щемелинская Ю.Л., Масчан А.А, Новичкова Г.А. – М. АО «Информатика», 2023. - 152 с.: ил. ISBN 978-5-6049537-2-3.;
Венозный катетер. Использование, уход, контроль, осложнения: учебное пособие / Сацук А.В., Солопова Г.Г., Щукин В.В., Литвинов Д.В., Пименова О.В. Климова Н.А., Щемелинская Ю.Л., Масчан А.А, Новичкова Г.А. – М. АО «Информатика», 2023. - 152 с.: ил. ISBN 978-5-6049537-2-3.;
Сопроводительная терапия и контроль инфекций при гематологических и онкологических заболеваниях [Electronic resource]. URL: https://elibrary.ru/item.asp?id=19537193 (accessed: 31.05.2024).
Mikulska M, Viscoli C, Orasch C, Livermore DM, Averbuch D, Cordonnier C et al. Aetiology and resistance in bacteriaemias among adult and paediatric haematology and cancer patients. Jornal of infection (2014), 68: 321-331.
Tam C.S. et al. Use of empiric antimicrobial therapy in neutropenic fever. Australian Consensus Guidelines 2011 Steering Committee // Intern. Med. J. 2011. Vol. 41, № 1b. P. 90–101.
L’Hotta A.J. et al. Clinical practice guideline and expert consensus recommendations for rehabilitation among children with cancer: A systematic review // CA. Cancer J. Clin. 2023. Vol. 73, № 5. P. 524–545.
Fischmeister G. et al. Rehabilitation for children and adolescents after cancer: importance and implementation in Austria // Memo - Mag. Eur. Med. Oncol. 2021. Vol. 14, № 3. P. 278–283.
Ospina P.A. et al. Physical Rehabilitation Practices for Children and Adolescents with Cancer in Canada // Physiother. Can. Physiother. Can. 2020. Vol. 72, № 2. P. 207–216.
Vasilyeva E.S., Vashura A., Litvinov D. Nutritional status of children with cancer and hematological malignancies during treatment in FSBI Federal Scientific Clinical Center of Pediatric Hematology, Oncology and Immunology named after Dmitry Rogachev (screening results) // Mod. Oncol. 2016. Vol. 18. P. 48–52.
Muscaritoli M. et al. ESPEN practical guideline: Clinical Nutrition in cancer // Clin. Nutr. Edinb. Scotl. 2021. Vol. 40, № 5. P. 2898–2913.
Практическое руководство по детским болезням. Т. 4. Гематология/онкология детского возраста [Electronic resource]. URL: https://mdk-arbat.ru/book/4292955 (accessed: 31.05.2024).
Mead G.M. et al. A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial // Br. J. Cancer. 2005. Vol. 93, № 2. P. 178–184.
Shatara M. et al. GCT-66. FINAL REPORT OF THE PROSPECTIVE NEXT/CNS-GCT-4 CONSORTIUM TRIAL (GemPOx FOLLOWED BY MARROW-ABLATIVE CHEMOTHERAPY) IN PATIENTS WITH REFRACTORY/RECURRENT CNS GERM CELL TUMORS // Neuro-Oncol. 2020. Vol. 22, № Suppl 3. P. iii341.
McGregor L.M. et al. Phase I Study of Oxaliplatin and Irinotecan in Pediatric Patients with Refractory Solid Tumors: A Children’s Oncology Group Study // Cancer. 2009. Vol. 115, № 8. P. 1765.
Saxman S. Oral etoposide in germ cell tumours // Drugs. 1999. Vol. 58 Suppl 3. P. 31–34.
Hulsker C.C.C. et al. Malignant extracranial germ cell tumors in the Netherlands between 1990 and 2018: Stable incidence and improved survival // EJC Paediatr. Oncol. 2024. Vol. 3. P. 100148.
Frazier A.L. et al. Revised risk classification for pediatric extracranial germ cell tumors based on 25 years of clinical trial data from the United Kingdom and United States // J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 2015. Vol. 33, № 2. P. 195–201.
Antiemetics: ASCO Guideline Update - PubMed [Electronic resource]. URL: https://pubmed.ncbi.nlm.nih.gov/32658626/ (accessed: 31.05.2024).
Naik R.D. et al. Olanzapine for Prevention of Vomiting in Children and Adolescents Receiving Highly Emetogenic Chemotherapy: Investigator-Initiated, Randomized, Open-Label Trial // J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 2020. Vol. 38, № 32. P. 3785–3793.
Эффективность и безопасность малых доз оланзапина в профилактике тошноты и рвоты у детей и подростков, получающих высокоэметогенную химиотерапию. Промежуточные результаты рандомизированного исследования | Жуков | Вопросы гематологии/онкологии и иммунопатологии в педиатрии [Electronic resource]. URL: https://www.hemoncim.com/jour/article/view/680?locale=ru_RU (accessed: 31.05.2024).
Patel P. et al. Dexamethasone dosing for prevention of acute chemotherapy-induced vomiting in pediatric patients: A systematic review // Pediatr. Blood Cancer. 2020. Vol. 67, № 12. P. e28716.
Efficacy, safety and cost effectiveness of reduced-dose olanzapine versus aprepitant as a part of triple-antiemetic therapy in the prevention of chemotherapy induced nausea and vomiting. | Journal of Clinical Oncology [Electronic resource]. URL: https://ascopubs.org/doi/10.1200/JCO.2022.40.16_suppl.e24078 (accessed: 31.05.2024).
Navari R.M. et al. Olanzapine With or Without Fosaprepitant for Preventing Chemotherapy Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy: A Phase III Randomized, Double-Blind, Placebo-Controlled Trial (ALLIANCE A221602) // The Oncologist. 2023. Vol. 28, № 8. P. 722–729.
Patil V. et al. Comparison of antiemetic efficacy and safety of palonosetron vs ondansetron in the prevention of chemotherapy-induced nausea and vomiting in children // J. Community Support. Oncol. 2015. Vol. 13, № 6. P. 209–213.
Chaudhary N.K. et al. Palonosetron is a Better Choice Compared With Ondansetron for the Prevention of Chemotherapy-induced Nausea and Vomiting (CINV) in a Resource-limited Pediatric Oncology Center: Results From a Randomized Control Trial // J. Pediatr. Hematol. Oncol. 2019. Vol. 41, № 4. P. 294–297.
Jain S. et al. A randomized, open-label non-inferiority study to compare palonosetron and ondansetron for prevention of acute chemotherapy-induced vomiting in children with cancer receiving moderate or high emetogenic chemotherapy // Support. Care Cancer Off. J. Multinatl. Assoc. Support. Care Cancer. 2018. Vol. 26, № 9. P. 3091–3097.
Flank J. et al. Guideline for the Treatment of Breakthrough and the Prevention of Refractory Chemotherapy-Induced Nausea and Vomiting in Children With Cancer // Pediatr. Blood Cancer. 2016. Vol. 63, № 7. P. 1144–1151.
Mehta N.M. et al. Defining pediatric malnutrition: a paradigm shift toward etiology-related definitions // JPEN J. Parenter. Enteral Nutr. 2013. Vol. 37, № 4. P. 460–481.
Jang R.W. et al. Simple prognostic model for patients with advanced cancer based on performance status // J. Oncol. Pract. 2014. Vol. 10, № 5. P. e335-341.
Martin L. et al. Diagnostic Criteria for the Classification of Cancer-Associated Weight Loss // J. Clin. Oncol. Wolters Kluwer, 2015. Vol. 33, № 1. P. 90–99.
Вашура А.Ю. et al. Роль и актуальность нутрициологического диагноза в онкопедиатрии: 12 // Медицинский Совет. 2023. Vol. 0, № 12. P. 99–109.
Yaprak D.S. et al. Assessment of nutritional status in children with cancer: Significance of arm anthropometry and serum visceral proteins // Pediatr. Blood Cancer. 2021. Vol. 68, № 1. P. e28752.
Pietilä S. et al. Obesity and metabolic changes are common in young childhood brain tumor survivors // Pediatr. Blood Cancer. 2009. Vol. 52, № 7. P. 853–859.
Rayar M. et al. Sarcopenia in children with acute lymphoblastic leukemia // J. Pediatr. Hematol. Oncol. 2013. Vol. 35, № 2. P. 98–102.
Langius J.A.E. et al. Effect of nutritional interventions on nutritional status, quality of life and mortality in patients with head and neck cancer receiving (chemo)radiotherapy: a systematic review // Clin. Nutr. Edinb. Scotl. 2013. Vol. 32, № 5. P. 671–678.
Парентеральное и энтеральное питание детей : практические рекомендации [Electronic resource]. URL: https://www.rosmedlib.ru/book/ISBN9785970439920.html (accessed: 31.05.2024).
Bercovitz R.S., Josephson C.D. Transfusion Considerations in Pediatric Hematology and Oncology Patients // Hematol. Oncol. Clin. North Am. 2016. Vol. 30, № 3. P. 695–709.
Steiner M.E. et al. Recommendations on RBC Transfusion Support in Children With Hematologic and Oncologic Diagnoses From the Pediatric Critical Care Transfusion and Anemia Expertise Initiative // Pediatr. Crit. Care Med. J. Soc. Crit. Care Med. World Fed. Pediatr. Intensive Crit. Care Soc. 2018. Vol. 19, № 9S Suppl 1. P. S149–S156.
Shah N., Andrews J., Goodnough L.T. Transfusions for anemia in adult and pediatric patients with malignancies // Blood Rev. 2015. Vol. 29, № 5. P. 291–299.
Nellis M.E., Goel R., Karam O. Transfusion Management in Pediatric Oncology Patients // Hematol. Oncol. Clin. North Am. 2019. Vol. 33, № 5. P. 903–913.
ISBT. WHO Educational modules on clinical use of blood [Electronic resource]. URL: https://www.isbtweb.org/resource/who-educational-modules-on-clinical-use-of-blood.html (accessed: 31.05.2024).
O’Shaughnessy D.F. et al. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant // Br. J. Haematol. 2004. Vol. 126, № 1. P. 11–28.
Cellini M. et al. Guidelines of the Italian Association of Pediatric Hematology and Oncology for the management of the central venous access devices in pediatric patients with onco-hematological disease // J. Vasc. Access. 2022. Vol. 23, № 1. P. 3–17.
Cameron G.S. Central venous catheters for children with malignant disease: surgical issues // J. Pediatr. Surg. 1987. Vol. 22, № 8. P. 702–704.
Bonciarelli G. et al. GAVeCeLT* consensus statement on the correct use of totally implantable venous access devices for diagnostic radiology procedures // J. Vasc. Access. 2011. Vol. 12, № 4. P. 292–305.
Burbridge B. et al. Randomized Clinical Trial Evaluating Complications and Complication-Related Removal of Arm-Situated Power-Injectable and Non-Power-Injectable Totally Implanted Venous Access Devices among Cancer Patients // J. Vasc. Interv. Radiol. JVIR. 2018. Vol. 29, № 5. P. 648-656.e3.
Skinner R. et al. Prevention and management of central venous catheter occlusion and thrombosis in children with cancer // Pediatr. Blood Cancer. 2008. Vol. 50, № 4. P. 826–830.
Thurman C.B. et al. Risk for Health Care-Associated Bloodstream Infections in Pediatric Oncology Patients With Various Malignancies // J. Pediatr. Oncol. Nurs. Off. J. Assoc. Pediatr. Oncol. Nurses. 2017. Vol. 34, № 3. P. 196–202.
Pittiruti M. et al. European recommendations on the proper indication and use of peripheral venous access devices (the ERPIUP consensus): A WoCoVA project // J. Vasc. Access. 2023. Vol. 24, № 1. P. 165–182.
Lehrnbecher T. et al. Guideline for the management of fever and neutropenia in children with cancer and/or undergoing hematopoietic stem-cell transplantation // J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 2012. Vol. 30, № 35. P. 4427–4438.
Simon A. et al. Surveillance of bloodstream infections in pediatric cancer centers – what have we learned and how do we move on? // GMS Hyg. Infect. Control. 2016. Vol. 11. P. Doc11.
Martínez Campos L. et al. Consensus document on the management of febrile neutropenia in paediatric haematology and oncology patients of the Spanish Society of Pediatric Infectious Diseases (SEIP) and the Spanish Society of Pediatric Hematology and Oncology (SEHOP) // An. Pediatr. 2023. Vol. 98, № 6. P. 446–459.
Campbell C.T., Poisson M.O., Hand E.O. An Updated Review of Clostridium difficile Treatment in Pediatrics // J. Pediatr. Pharmacol. Ther. JPPT Off. J. PPAG. 2019. Vol. 24, № 2. P. 90–98.
Dufrayer M.C. et al. Safety of levofloxacin as an antibiotic prophylaxis in the induction phase of children newly diagnosed with acute lymphoblastic leukemia: an interim analysis of a randomized, open-label trial in Brazil // Braz. J. Infect. Dis. Brazilian Society of Infectious Diseases, 2023. Vol. 27. P. 102745.
Chibabhai V. et al. Appropriate use of colistin in neonates, infants and children: Interim guidance // South. Afr. J. Infect. Dis. 2023. Vol. 38, № 1. P. 555.
Iosifidis E. et al. Use of Tigecycline in Pediatric Patients With Infections Predominantly Due to Extensively Drug-Resistant Gram-Negative Bacteria // J. Pediatr. Infect. Dis. Soc. 2017. Vol. 6, № 2. P. 123–128.
Araujo da Silva A.R., Quijada R. Use of Ceftazidime-Avibactam in Children Admitted to Pediatric Intensive Care Units // Child. Basel Switz. 2024. Vol. 11, № 6. P. 664.
Dellinger R.P. et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012 // Crit. Care Med. 2013. Vol. 41, № 2. P. 580–637.
Ferrer R. et al. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program // Crit. Care Med. 2014. Vol. 42, № 8. P. 1749–1755.
Morales Castro D. et al. Pharmacokinetic Alterations Associated with Critical Illness // Clin. Pharmacokinet. 2023. Vol. 62, № 2. P. 209–220.
Morrissey C.O. et al. Consensus guidelines for the use of empiric and diagnostic-driven antifungal treatment strategies in haematological malignancy, 2014 // Intern. Med. J. 2014. Vol. 44, № 12b. P. 1298–1314.
Ruhnke M., Schwartz S. Recent developments in the management of invasive fungal infections in patients with oncohematological diseases // Ther. Adv. Hematol. 2016. Vol. 7, № 6. P. 345–359.
Cordonnier C. et al. Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial // Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 2009. Vol. 48, № 8. P. 1042–1051.
D. A. Karnofsky and J. H. Burchenal, “The Clinical Evaluation of Chemotherapeutic Agents in Cancer,” In C. M. MacLeod, Ed., Evaluation of Chemotherapeutic Agents, Columbia University Press, New York, 1949, P. 196. - References - Scientific Research Publishing [Electronic resource]. URL: https://www.scirp.org/reference/ReferencesPapers?ReferenceID=966779 (accessed: 18.11.2024).
Oken M.M. et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group // Am. J. Clin. Oncol. 1982. Vol. 5, № 6. P. 649–655.
Miller JC, Einhorn LH. Phase II study of daily oral etoposide in refractory germ cell tumors. Semin
Oncol. 1990 Feb;17(1 Suppl 2):36-9. PMID: 2154858
https://www.eortc.be/services/forms/1407/1407%20Tiger-Outline%2020140919.pdf